Patents by Inventor Rikke Louise Vinther Skjot

Rikke Louise Vinther Skjot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TB diagnostic based on antigens from
    Patent number: 8076469
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as diagnostic reagents containing the polypeptides.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: December 13, 2011
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Karin Weldingh, Christina Veggerby Hansen, Walter Florio, Li Mei Meng Okkels, Rikke Louise Vinther Skjot, Peter Birk Rasmussen
  • Tuberculosis vaccine and diagnostics based on the sat-6 gene family
    Patent number: 7867502
    Abstract: This invention relates to a polypeptide fragment which comprises an amino acid sequence encoded by a member of the esat-6 gene. A member of the esat-6 gene family is defined as gene encoding a small protein and that two such genes are arranged next to each other on the genome and that at least one of the gene products has an amino acid sequence identity to either Rv3874, Rv3875, or Rv0288 of at least 15%.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: January 11, 2011
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Rikke Louise Vinther Skjot
  • TB DIAGONOSTIC BASED ON ANTIGENS FROM M. TUBERCULOSIS
    Publication number: 20080267990
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as diagnostic reagents containing the polypeptides.
    Type: Application
    Filed: November 1, 2007
    Publication date: October 30, 2008
    Applicant: STATENS SERUM INSTITUT
    Inventors: Peter Andersen, Karin Weldingh, Christina Veggerby Hansen, Walter Florio, Li Mei Meng Okkels, Rikke Louise Vinther Skjot, Peter Birk Rasmussen
  • Hybrids of M. tuberculosis antigens
    Patent number: 7037510
    Abstract: The present invention discloses fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues thereof, and a tuberculosis vaccine based on the fusion proteins, which vaccine induces efficient immunological memory.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: May 2, 2006
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Anja Weinreich Olsen, Rikke Louise Vinther Skjøt, Peter Birk Rasmussen
  • M. tuberculosis antigens
    Patent number: 6991797
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: January 31, 2006
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Rikke Louise Vinther Skjøt
  • TB diagnostic based on antigens from M. tuberculosis
    Patent number: 6982085
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as diagnostic reagents containing the polypeptides.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: January 3, 2006
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Karin Weldingh, Christina Veggerby Hansen, Walter Florio, Li Mei Meng Okkels, Rikke Louise Vinther Skjot, Peter Birk Rasmussen
  • Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
    Publication number: 20040013685
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptide.
    Type: Application
    Filed: June 1, 2001
    Publication date: January 22, 2004
    Inventors: Peter Andersen, Rikke Louise Vinther Skjot, Li Mei Meng Okkels, Inger Brock, Thomas Oettinger
  • TB diagnostic based on antigens from M. tuberculosis
    Publication number: 20030165525
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as diagnostic reagents containing the polypeptides.
    Type: Application
    Filed: May 2, 2002
    Publication date: September 4, 2003
    Inventors: Peter Andersen, Karin Weldingh, Christina Veggerby Hansen, Walter Florio, Li Mei Meng Okkels, Rikke Louise Vinther Skjot, Peter Birk Rasmussen
  • M. tuberculosis antigens
    Publication number: 20030147897
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides.
    Type: Application
    Filed: March 13, 2001
    Publication date: August 7, 2003
    Inventors: Peter Andersen, Rikke Louise Vinther Skjot
  • Hybrids of M. tuberculosis antigens
    Publication number: 20020176867
    Abstract: The present invention discloses fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues thereof, and a tuberculosis vaccine based on the fusion proteins, which vaccine induces efficient immunological memory.
    Type: Application
    Filed: March 13, 2001
    Publication date: November 28, 2002
    Inventors: Peter Andersen, Anja Weinreich Olsen, Rikke Louise Vinther Skjot, Peter Birk Rasmussen